Transgene SA
TRGNF
$0.85
-$0.15-15.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.61M | -10.66M | -10.95M | -10.15M | -9.32M |
| Total Depreciation and Amortization | 384.20K | 385.80K | 377.90K | 350.40K | 359.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 692.90K |
| Total Other Non-Cash Items | 949.90K | 954.00K | 1.20M | 1.11M | -1.66M |
| Change in Net Operating Assets | -1.84M | -1.85M | -812.60K | -753.50K | 7.26M |
| Cash from Operations | -11.12M | -11.17M | -10.18M | -9.44M | -2.67M |
| Capital Expenditure | -327.70K | -329.10K | -158.30K | -146.80K | -566.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.00M | -61.26M | -178.20K | -165.20K | -372.00K |
| Cash from Investing | -61.32M | -61.59M | -336.50K | -312.00K | -938.10K |
| Total Debt Issued | -10.15M | -10.15M | 10.15M | 10.15M | -10.00M |
| Total Debt Repaid | 0.00 | 0.00 | -8.50K | -8.50K | -36.50K |
| Issuance of Common Stock | 52.56M | 52.56M | -- | -- | 55.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.92M | 14.92M | -119.50K | -119.50K | 13.84M |
| Cash from Financing | 66.73M | 67.02M | 11.37M | 10.55M | 4.12M |
| Foreign Exchange rate Adjustments | -180.40K | -181.20K | -795.60K | -737.70K | 212.70K |
| Miscellaneous Cash Flow Adjustments | 600.00 | 600.00 | -600.00 | -500.00 | -- |
| Net Change in Cash | -5.89M | -5.91M | 57.90K | 53.70K | 719.50K |